var data={"title":"Clindamycin (topical): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Clindamycin (topical): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/387893?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=clindamycin-topical-patient-drug-information\" class=\"drug drug_patient\">see &quot;Clindamycin (topical): Patient drug information \t&quot;</a> and <a href=\"topic.htm?path=clindamycin-topical-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Clindamycin (topical): Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008024\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Cleocin;</li>\n      <li>Cleocin-T;</li>\n      <li>Clindacin ETZ;</li>\n      <li>Clindacin Pac;</li>\n      <li>Clindacin-P;</li>\n      <li>Clindagel;</li>\n      <li>ClindaMax [DSC];</li>\n      <li>Clindesse;</li>\n      <li>Evoclin</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008025\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Clinda-T;</li>\n      <li>Clindasol;</li>\n      <li>Clindets;</li>\n      <li>Dalacin T;</li>\n      <li>Dalacin Vaginal</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008029\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Antibiotic, Lincosamide;</li>\n      <li>\n        Topical Skin Product, Acne</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008109\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Acne:</b>\n      <i> Topical: </i></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Gel (Cleocin T, ClindaMax), pledget, lotion, solution: Apply a thin film twice daily</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Gel (Clindagel), foam (Evoclin): Apply once daily</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Bacterial vaginosis:</b> <i>Intravaginal: </i></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Suppositories: Insert one suppository (100 mg clindamycin) daily into vagina at bedtime for 3 days</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cream:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Cleocin: One full applicator inserted intravaginally once daily before bedtime for 3 or 7 consecutive days in nonpregnant patients or for 7 consecutive days in pregnant patients</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Clindesse: One full applicator inserted intravaginally as a single dose at anytime during the day in nonpregnant patients</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Alternate dosing:</i> Pregnant or non-pregnant patients: Intravaginal:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Cream (preferred): One full applicator (5 g) at bedtime for 7 days (CDC [Workowski 2015])</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Suppository (alternative therapy): One suppository (100 mg) daily at bedtime for 3 days (CDC [Workowski 2015]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Hidradenitis suppurativa (off-label use):</b> <i>Topical: </i>Solution: Apply to affected area twice daily (Jemec 2012)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Rosacea (off-label use):</b> <i>Topical:</i> Lotion: Apply twice daily to the face (Wilkin 1993)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008108\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=clindamycin-topical-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Clindamycin (topical): Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Acne:</b>\n      <i> Topical: </i>Children &ge;12 years and Adolescents: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008110\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50221301\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50221303\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008157\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Cream, Vaginal, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin: 2% (40 g) [contains benzyl alcohol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindesse: 2% (5 g, 5.8 g [DSC]) [contains disodium edta, methylparaben, propylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 2% (40 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Foam, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Evoclin: 1% (50 g, 100 g) [contains cetyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (50 g, 100 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Gel, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin-T: 1% (30 g, 60 g) [contains methylparaben, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindagel: 1% (75 mL) [contains methylparaben, polyethylene glycol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">ClindaMax: 1% (30 g [DSC], 60 g [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (30 g, 60 g)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Kit, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindacin ETZ: 1% [contains cetyl alcohol, isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindacin Pac: 1% [contains cetyl alcohol, isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Lotion, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin-T: 1% (60 mL) [contains cetostearyl alcohol, methylparaben]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (60 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin-T: 1% (30 mL, 60 mL) [contains isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (30 mL, 60 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Suppository, Vaginal, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin: 100 mg (3 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Swab, External, as phosphate [strength expressed as base]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin-T: 1% (60 ea) [contains isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindacin ETZ: 1% (60 ea) [contains isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindacin-P: 1% (69 ea) [contains isopropyl alcohol, propylene glycol]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (60 ea)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008027\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008123\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Intravaginal:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cream: Insertion with the applicator should be as far as possible into the vagina without causing discomfort.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Suppository: Remove from packaging prior to use; if applicator is used for insertion, wash after each use.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Topical:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Foam: Dispense directly into cap or onto a cool surface; do not dispense directly into hands or face (foam will melt on contact with warm skin). Wash skin with mild soap and allow to fully dry. Apply in small amounts to face using fingertips and gently massage into affected areas until foam disappears. Avoid contact with eyes, mouth, lips, mucous membranes, or broken skin.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Gel: Avoid contact with eyes.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Lotion: Shake well immediately before using.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Solution or pledget: Avoid contact with eyes, mouth or other mucous membranes; solution/pledget contains an alcohol base and if inadvertent contact with mucous membranes occurs, rinse with liberal amounts of water. Remove pledget from foil immediately before use; discard after single use. May use more than one pledget for each application to cover area.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008040\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Acne vulgaris:</b> Treatment of acne vulgaris (topical gel, topical lotion, topical solution)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Bacterial vaginosis:</b> Treatment of bacterial vaginosis (vaginal cream, vaginal suppository)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25873076\" class=\"block off-label drugH1Div\"><span class=\"drugH1\">Use: Off-Label</span>\n    <p>Hidradenitis suppurativa; Rosacea</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8007985\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Cleocin may be confused with bleomycin, Clinoril, Cubicin, Lincocin</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindamycin may be confused with clarithromycin, Claritin, vancomycin</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Clindesse may be confused with Clindets [Canada]</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008056\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">\n      <b>Topical:</b> &gt;10%: Dermatologic: Xeroderma (18% to 23%; gel, lotion, solution), oily skin (gel, lotion: 10% to 18%; solution: 1%), erythema (7% to 16%; gel, lotion, solution), burning sensation of skin (10% to 11%; gel, lotion, solution), exfoliation of skin (7% to 11%; lotion, solution), pruritus (7% to 11%; gel, lotion, solution)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">\n      <b>Vaginal:</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">&gt;10%: Genitourinary: Vaginal moniliasis (&le;13%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">1% to 10%:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Dermatologic: Pruritus (&le;1% nonapplication site; &lt;1% application site)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Genitourinary: Vulvovaginal disease (3% to 9%), vulvovaginitis (&le;7%), vaginal pain (2%), trichomonal vaginitis (&le;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Infection: Fungal infection (&le;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">&lt;1%, postmarketing, and/or case reports (all routes): Abdominal cramps, abdominal pain, application site pain, bacterial infection, bloody diarrhea, colitis, constipation, contact dermatitis, diarrhea (hemorrhagic or severe), dizziness, dysgeusia, dyspepsia, dysuria, edema, endometriosis, epistaxis, erythema, eye pain, fever, flank pain, flatulence, folliculitis, folliculitis (gram-negative infection), gastrointestinal disease, gastrointestinal distress, halitosis, headache, hypersensitivity reaction, hyperthyroidism, maculopapular rash, menstrual disease, nausea, pain, pseudomembranous colitis, pyelonephritis, severe colitis, skin rash, upper respiratory infection, urinary tract infection, urticaria, uterine hemorrhage, vaginal discharge, vertigo, vomiting, vulvovaginal pruritus</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008043\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;margin-left:0em;display:inline\">Hypersensitivity to clindamycin, lincomycin, or any component of the formulation; history of antibiotic-associated colitis, regional enteritis, ulcerative colitis.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008054\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Colitis: Use may result in fungal or bacterial superinfection, including <i>C. difficile</i>-associated diarrhea (CDAD); CDAD has been observed &gt;2 months postantibiotic treatment. Discontinue drug if significant diarrhea, abdominal cramps, or passage of blood and mucus occurs.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Atopic patients: Use with caution in atopic patients.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Topical foam: Topical foam may cause irritation especially when used with abrasive, desquamating or peeling agents; avoid contact with eyes, mouth, lips, mucous membranes, or broken skin.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Topical pledget or solution: Topical pledget and topical solution contain an alcohol base and may cause eye irritation or burning. Rinse with cool tap water if product comes in contact with mucous membranes, abraded skin, or eyes. Use caution when applying near mouth (unpleasant taste).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Vaginal products: May weaken condoms, or contraceptive diaphragms; barrier contraceptives are not recommended concurrently or for 3-5 days (depending on the product) following treatment. Vaginal cream contains ingredients that may cause eye burning and irritation; rinse with cool tap water if product comes in contact with the eyes.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>\n        <b>Other warnings/precautions:</b></i></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: Acne: American Academy of Dermatology (AAD) acne guidelines recommend clindamycin (topical) be used in conjunction with other therapies (<i>not</i> as monotherapy) due to the risk of bacterial resistance. If given for mild acne, clindamycin (topical) should be used in combination with benzoyl peroxide. If given for moderate to severe acne, it should be used in combination with a topical retinoid or systemic antibiotic agent (AAD [Zaenglein 2016]).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299058\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8018207\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9065&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Erythromycin (Systemic): May diminish the therapeutic effect of Clindamycin (Topical).<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Erythromycin (Topical): May diminish the therapeutic effect of Clindamycin (Topical).<i> Risk X: Avoid combination</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Neuromuscular-Blocking Agents: Clindamycin (Topical) may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8018205\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">B (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9749572\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;\">Adverse effects were not observed in animal reproduction studies. Clindamycin has been shown to cross the placenta following oral and parenteral dosing (Philipson 1973; Weinstein 1976). The amount of clindamycin available systemically is less following topical and vaginal application than with IV or oral administration.</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Various clindamycin vaginal products are available for the treatment of bacterial vaginosis. Recommendations for use in pregnant woman vary by product labeling. Current guidelines note that the same oral or vaginal regimens used in nonpregnant women may be used during pregnancy, including oral or vaginal clindamycin (CDC [Workowski 2015]).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">If treatment for acne is needed during pregnancy, topical clindamycin may be considered if an antibiotic is needed. To decrease systemic exposure, pregnant women should avoid application to inflamed skin for long periods of time, or to large body surface areas (Kong 2013).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F9749575\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">It is not known if clindamycin is present in breast milk following vaginal or topical administration. According to the manufacturer, the decision to continue or discontinue breastfeeding during therapy should take into account the risk of infant exposure, the benefits of breastfeeding to the infant, and benefits of treatment to the mother. If clindamycin is used topically to the chest for the treatment of acne in women who are breastfeeding, care should be taken to avoid accidental ingestion by the infant. To decrease systemic exposure, breastfeeding women should avoid application to inflamed skin for long periods of time, or to large body surface areas (Kong 2013).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Clindamycin can be detected in breast milk following oral and IV dosing. Systemic clindamycin concentrations are less following topical and vaginal application. This minimal absorption should minimize potential exposure to a breastfeeding infant. Nondose-related effects could include modification of bowel flora.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008079\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Reversibly binds to 50S ribosomal subunits preventing peptide bond formation thus inhibiting bacterial protein synthesis; bacteriostatic or bactericidal depending on drug concentration, infection site, and organism</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008081\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Absorption: Topical solution or foam, phosphate: Minimal; Vaginal cream, phosphate: ~5%; Vaginal suppository, phosphate: ~30%</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metabolism: Hepatic; forms metabolites (variable activity); Clindamycin phosphate is converted to clindamycin HCl (active)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Half-life elimination: Vaginal cream: 1.5 to 2.6 hours following repeated dosing; Vaginal suppository: 11 hours (range: 4 to 35 hours, limited by absorption rate)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Time to peak, serum: Vaginal cream: ~10 to 14 hours (range: 4 to 24 hours); Vaginal suppository: ~5 hours (range: 1 to 10 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: Urine (&lt;0.2% with topical foam and solution)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F8008159\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Cleocin Vaginal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (40 g): $230.88</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Clindamycin Phosphate Vaginal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (40 g): $108.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Cream</b> (Clindesse Vaginal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2% (5 g): $139.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Foam</b> (Clindamycin Phosphate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (50 g): $346.74</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Foam</b> (Evoclin External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (50 g): $571.79</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Cleocin-T External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (30 g): $180.53</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Clindagel External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (75 mL): $2,132.71</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (Clindamycin Phosphate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (30 g): $86.38</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Clindacin ETZ External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (1): $545.11</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Kit</b> (Clindacin Pac External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (1): $567.92</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Cleocin-T External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (60 mL): $251.17</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Lotion</b> (Clindamycin Phosphate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (60 mL): $120.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Cleocin-T External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (30 mL): $87.61</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Clindamycin Phosphate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (30 mL): $40.81</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (Cleocin Vaginal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">100 mg (3): $210.96</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Swab</b> (Cleocin-T External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (60): $237.95</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Swab</b> (Clindacin ETZ External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (60): $545.11</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Swab</b> (Clindacin-P External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (69): $567.92</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Swab</b> (Clindamycin Phosphate External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (60): $46.40</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F10961962\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Acnegon (LK);</li>\n      <li>Albiotin Acne (LK);</li>\n      <li>Aledo Gel (TW);</li>\n      <li>Avocin (KW, QA, SA);</li>\n      <li>Butamycin-N (GR);</li>\n      <li>Chinacin-T (TH);</li>\n      <li>Clearex (SY);</li>\n      <li>Cleocin T (KR, TW);</li>\n      <li>Cleocin-T (BB);</li>\n      <li>Clicia Solution (KR);</li>\n      <li>Clidan (UY);</li>\n      <li>Clidets Gel (MX);</li>\n      <li>Clinagel (BR);</li>\n      <li>Clindac-A (IN);</li>\n      <li>Clindacin (AR, BD, RU);</li>\n      <li>Clindacin T (AE);</li>\n      <li>Clindagel (GR);</li>\n      <li>Clindamycin-T (SA);</li>\n      <li>Clindasol (SA);</li>\n      <li>ClindaTech (PH);</li>\n      <li>Clindax Lotion (BD);</li>\n      <li>Clinderm (PH);</li>\n      <li>Clinex (BD);</li>\n      <li>Cliniderm (LB);</li>\n      <li>Clinika (ID);</li>\n      <li>Clinimycin (KW, QA);</li>\n      <li>Clinimycin T (LB);</li>\n      <li>Clinimycin-T (SA);</li>\n      <li>Clintopic (UY);</li>\n      <li>Clinwas (ES);</li>\n      <li>Cutaclin (CR, DO, GT, HN, MX, NI, PA, PE, SV);</li>\n      <li>Daclin (BD);</li>\n      <li>Dalacin (BE, DK, ES, FI, HU, IS, LU, NO, SI);</li>\n      <li>Dalacin al 1% (VE);</li>\n      <li>Dalacin C Lotion (TR);</li>\n      <li>Dalacin Lotion (AT);</li>\n      <li>Dalacin Solution (AT);</li>\n      <li>Dalacin T (AE, AU, BG, BH, BR, CH, CL, CN, CO, CZ, DK, EE, EG, GB, HK, IE, IT, JO, KW, LV, MT, MX, MY, NL, PE, PK, PL, PT, QA, SA, SG, SK, TH, UA, VN, ZA);</li>\n      <li>Dalacin T Gel (CR, DO, HN, NI, PA, SV);</li>\n      <li>Dalacine (FR);</li>\n      <li>Dalacine T (FR);</li>\n      <li>Derma T (KW, QA);</li>\n      <li>Derma-T (AE, SA);</li>\n      <li>Dermabel (CL);</li>\n      <li>Duoclin (KR);</li>\n      <li>Edason Cutaneous (MT);</li>\n      <li>Glencin T (AE);</li>\n      <li>Kolincin (HK);</li>\n      <li>Lindamax (BD);</li>\n      <li>Medacin T (LB);</li>\n      <li>Mediacin T (AE);</li>\n      <li>Mediklin (ID);</li>\n      <li>Rosil (TH);</li>\n      <li>T3 Mycin Gel (VN);</li>\n      <li>T3-Mycin (ET);</li>\n      <li>T3Mycin (HK, PH, SG);</li>\n      <li>Tidact Gel (MY);</li>\n      <li>Topicil (SG);</li>\n      <li>Zindaclin (BE, CZ, ES, GB, HK, IE, IL, LB, MY, PL, PT, TR);</li>\n      <li>Zindacline (FR)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/11487763/pubmed\" target=\"_blank\" id=\"11487763\">11487763</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Barza M, Goldstein JA, Kane A, et al, &ldquo;Systemic Absorption of Clindamycin Hydrochloride After Topical Application,&rdquo; <i>J Am Acad Dermatol</i>, 1982, 7(2):208-14.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/6215432/pubmed\" target=\"_blank\" id=\"6215432\">6215432</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol&mdash;United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"6347922\"></a>Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. <i>Int J Dermatol</i>. 1983;22(5):325-328.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/6347922/pubmed\" target=\"_blank\" id=\"6347922\">6347922</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cleocin T topical solution (clindamycin) [prescribing information]. New York, NY: Pharmacia &amp; Upjohn; November 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cleocin vaginal cream (clindamycin) [prescribing information]. New York, NY: Pharmacia &amp; Upjohn; September 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cleocin vaginal suppository (clindamycin) [prescribing information]. New York, NY: Pharmacia &amp; Upjohn; September 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Clindagel (clindamycin) [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals; November 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Clindesse vaginal cream (clindamycin) [prescribing information]. Allegan, MI: Perrigo; November 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Clindets pledgets (clindamycin solution) [product monograph]. Mississauga, Ontario, Canada: GlaxoSmithKline Inc; October 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Falagas ME and Gorbach SL, &ldquo;Clindamycin and Metronidazole,&rdquo; <i>Med Clin North Am</i>, 1995, 79(4):845-67.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/7791427/pubmed\" target=\"_blank\" id=\"7791427\">7791427</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      <a name=\"22236226\"></a>Jemec GB. Clinical practice. Hidradenitis suppurativa. <i>N Engl J Med</i>. 2012;366(2):158-164.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/22236226/pubmed\" target=\"_blank\" id=\"22236226\">22236226</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and lactation. <i>Drugs</i>. 2013;73(8):779-787.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/23657872 /pubmed\" target=\"_blank\" id=\"23657872 \">23657872 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Philipson A, Sabath LD, and Charles D, &quot;Transplacental Passage of Erythromycin and Clindamycin,&quot; <i>N Engl J Med</i>, 1973, 288(23):1219-21.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/4700555/pubmed\" target=\"_blank\" id=\"4700555\">4700555</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Smilack JD, Wilson WR, and Cockerill FR 3d, &ldquo;Tetracyclines, Chloramphenicol, Erythromycin, Clindamycin, and Metronidazole,&rdquo; <i>Mayo Clin Proc</i>, 1991, 66(12):1270-80.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/1749296/pubmed\" target=\"_blank\" id=\"1749296\">1749296</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Weinstein AJ, Gibbs RS, and Gallagher M, &quot;Placental Transfer of Clindamycin and Gentamicin in Term Pregnancy,&quot; <i>Am J Obstet Gynecol</i>, 1976, 124(7):688-91.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/943947/pubmed\" target=\"_blank\" id=\"943947\">943947</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wilkin JK, DeWitt S. Treatment of rosacea: topical clindamycin versus oral tetracycline. <i>Int J Dermatol</i>. 1993;32(1):65-67.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/8425809/pubmed\" target=\"_blank\" id=\"8425809\">8425809</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Workowski KA, Bolan GA; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2015. <i>MMWR Recomm Rep</i>. 2015;64(RR-03):1-137.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wynn RL and Bergman SA, &ldquo;Antibiotics and Their Use in the Treatment of Orofacial Infections, Part I and Part II,&rdquo; <i>Gen Dent</i>, 1994, 42(5):398-402, 498-502.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/clindamycin-topical-drug-information/abstract-text/7489869/pubmed\" target=\"_blank\" id=\"7489869\">7489869</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wynn RL, &ldquo;Clindamycin: An Often Forgotten but Important Antibiotic,&rdquo; <i>AGD Impact</i>, 1994, 22:10.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    \n      Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973.e33. http://www.jaad.org/article/S0190-9622(15)02614-6/pdf. Accessed June 13, 2016.26897386</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9065 Version 196.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F8008024\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F8008025\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F8008029\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F8008109\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F8008108\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F8008110\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F50221301\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F50221303\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F8008157\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F8008027\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F8008123\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F8008040\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Use: Off-Label\" href=\"#F25873076\" class=\"outlineLink\">Use: Off-Label</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F8007985\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F8008056\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F8008043\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F8008054\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299058\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F8018207\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F8018205\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F9749572\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F9749575\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F8008079\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F8008081\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F8008159\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F10961962\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9065|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=clindamycin-topical-patient-drug-information\" class=\"drug drug_patient\">Clindamycin (topical): Patient drug information \t</a></li><li><a href=\"topic.htm?path=clindamycin-topical-pediatric-drug-information\" class=\"drug drug_pediatric\">Clindamycin (topical): Pediatric drug information</a></li></ul></div></div>","javascript":null}